Although there were some studies revealed the cell resistant by CaMK II may be through the Fas pathway, our findings provided a new vision of CAMK2D that may regulate common pathogenesis of schizophrenia and glioma so that the potential treatments of schizophrenia could be found in the glioma pathway, and vice versa. Here, FAS is linked to schizophrenia.